8 results  1 of 1 

1 Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
Jin Hyoung Kang, Jung Hye Kwon, Yun-Gyoo Lee, Keon Uk Park, Ho Jung An, Joohyuk Sohn, Young Mi Seol, Hyunwoo Lee, Hwan-Jung Yun, Jin Seok Ahn, Ji Hyun Yang, Hunho Song, Dong-Hoe Koo, Jin Young Kim, Gun Min Kim, Hwa Jung Kim
Cancer Res Treat.2020;52(3):907-916.   Published online 2020 March 18     DOI: http://dx.doi.org/10.4143/crt.2019.713
      
2 Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens
Jennifer Holder-Murray, Stephen A Esper, Michael L Boisen, Julie Gealey, Katie Meister, David S Medich, Kathirvel Subramaniam
Korean J Anesthesiol.2019;72(4):344-350.   Published online 2019 May 17     DOI: http://dx.doi.org/10.4097/kja.d.18.00355
      
3 Aprepitant prophylaxis effectively reduces preventing postoperative nausea and vomiting in patients receiving opioid based intravenous patient-controlled analgesia
Gwieun Yeo, Mi Kyoung Lee, Heezoo Kim, Myounghoon Kong, Hyo Jung Son, Han Byeol Oh
Anesth Pain Med.2018;13(3):256-263.   Published online 2018 July 31     DOI: http://dx.doi.org/10.17085/apm.2018.13.3.256
      
4 Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia
Jae Hwa Yoo, Soon Im Kim, Ji Won Chung, Mi Roung Jun, Yoo Mi Han, Yong Jik Kim
Korean J Anesthesiol.2018;71(6):440-446.   Published online 2018 May 30     DOI: http://dx.doi.org/10.4097/kja.d.18.00011
      
5 Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
Satoe Fujiwara, Yoshito Terai, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Masahide Ohmichi
J Gynecol Oncol.2015;26(4):311-319.   Published online 2015 July 20     DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.311
      
6 A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients
Geundoo Jang, Hun Ho Song, Keon Uk Park, Hyeong Su Kim, Dae Ro Choi, Jung Hye Kwon, Ho Young Kim, Boram Han, Jung Han Kim, Joo Young Jung, Hyo Jung Kim, Dae Young Zang
Cancer Res Treat.2013;45(3):172-177.   Published online 2013 September 30     DOI: http://dx.doi.org/10.4143/crt.2013.45.3.172
      
7 Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting
Chae Seong Lim, Young-Kwon Ko, Yoon-Hee Kim, Sang-Il Park, Jae-Kook Kim, Myoung-Joong Kim, Hyun-Joong Kim
Korean J Anesthesiol.2013;64(3):212-217.   Published online 2013 March 19     DOI: http://dx.doi.org/10.4097/kjae.2013.64.3.212
      
8 The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone
Se-Jin Lee, Su Myung Lee, Soon Im Kim, Si Young Ok, Sang Ho Kim, Sun-Young Park, Mun-Gyu Kim
Korean J Anesthesiol.2012;63(3):221-226.   Published online 2012 September 14     DOI: http://dx.doi.org/10.4097/kjae.2012.63.3.221
      

 1 of 1